Paul M Reilly

age ~46

from Wilton, CT

Get Report

Also known as:

Cassandra Lyons

Connected to:

Paul Reilly Phones & Addresses

Wilton, CT
Brandon, VT
Trumbull, CT
44 Orange St, New Haven, CT 06510 • 2037898327
44 Orange St #614, New Haven, CT 06510 • 2037898327
Falls Church, VA
Arlington, VA
Brookfield, CT
Grand Rapids, MI

Work

Company:

Granite telecommunications
2014
Position:

Account manager

Education

School / High School:

Suffolk Community College- Brentwood, NY
2011

Medicine Doctors

Paul A. Reilly

view source

Specialties:

Internal Medicine

Work:

Paul Reilly MD
315 7 St, New Kensington, PA 15068
7243376232 (phone), 7243376721 (fax)

Education:

Medical School
Manila Central Univ, Coll of Med, Caloocan City, Rizal, Philippines
Graduated: 1981

Procedures:

Cardiac Stress Test
Allergen Immunotherapy
Arthrocentesis
Echocardiogram
Electrocardiogram (EKG or ECG)
Skin Tags Removal
Vaccine Administration

Conditions:

Abdominal Hernia
Abnormal Vaginal Bleeding
Acne
Acute Bronchitis
Acute Conjunctivitis

Languages:

English

Description:

Dr. Reilly graduated from the Manila Central Univ, Coll of Med, Caloocan City, Rizal, Philippines in 1981. He works in New Kensington, PA and specializes in Internal Medicine. Dr. Reilly is affiliated with Allegheny Valley Hospital.

Paul Jaye Reilly

view source

Specialties:

Family Medicine
Allergy & Immunology
Emergency Medicine
General Practice

Education:

University of Miami(1980)

Paul David Reilly

view source

Specialties:

Psychiatry

Education:

Virginia Commonwealth University (1983)

Name / Title

Company / Classification

Phones & Addresses

Paul Reilly
Owner

Prs Courier Worldwide Inc
Business Services

23 Greenway St, Stamford, CT 06907
Website: prscourierusa.com

Paul J Reilly
Director

ARROW ENTERPRISE COMPUTING SOLUTIONS, INC

2390 E Camelback Rd, Phoenix, AZ 85016
70 Maxess Rd, Melville, NY 11747
Director 70 Maxess Rd, Melville, NY 11747

Paul Reilly
Cfo

NU HORIZONS ELECTRONICS CORP

70 Maxess Rd, Melville, NY 11747
50 Marcus Dr, Melville, NY 11747

Paul Reilly
Principal

Greeley LLC
Business Services at Non-Commercial Site · Nonclassifiable Establishments

15009 Greymont Dr, Centreville, VA 20120

Paul J. Reilly
Branch Manager

Arrow Electronics, Inc
Ret Misc Merchandise

70 Maxess Rd, Huntington Station, NY 11747

Paul Reilly
Chairman, Chief Financial Offi, CFO

Arrow Electronics Inc
Electronic Parts/Equipment · Whol Electronic Parts/Equipment Whol Computers/Peripherals · Wholesale Electronic Parts/Equipment Computers/Peripherals · Whol Electronic Parts/Equipment · Whol Computers/Peripherals

6318472000, 6318472915

Paul Reilly
Vice Presi

ARROW SYSTEMS INTEGRATION, INC

50 Marcus Dr, Melville, NY 11747
70 Maxess Rd, Melville, NY 11747

Paul Reilly
Global Segment Manager-Telecom Industry Marketing

International Business Machines Corporation (IBM)

1 New Orch Rd, Armonk, NY 10504
New Orch Rd, Armonk, NY 10504
2 New Orch Rd, Armonk, NY 10504
9144991900, 9147661852, 9144991901, 3018077001

Resumes

Paul Reilly Commack, NY

view source

Work:

Granite Telecommunications

2014 to 2014
Account Manager Hamlet Golf & Country Club

2008 to 2014
Service Captain Eastern American Data/Voice, Inc.

2010 to 2011
Account Manager AT&T INTERACTIVE
Melville, NY
2009 to 2010
Account Premise Sales Representative SAVVIS COMMUNICATIONS
New York, NY
2008 to 2008
Senior Account Executive

Us Patents

New Pharmaceutical Compositions For Treatment Of Thrombosis
view source
US Patent:

20060222640, Oct 5, 2006
Filed:

Mar 26, 2006
Appl. No.:

11/277503
Inventors:

Paul Reilly - Danbury CT, US
James Gilbert - Bethlehem CT, US
Thomas Mueller - Danbury CT, US
Assignee:

Boehringer Ingelheim International GmbH - Ingelheim
International Classification:

A61K 38/48
A61K 31/727
A61K 31/4439
US Classification:

424094640, 514338000, 514056000
Abstract:

The present invention relates to novel pharmaceutical compositions comprising at least one direct thrombin inhibitor and at least one additional active compound selected from the groups consisting of platelet inhibitors, low molecular weight heparins (LMWH) and heparinoids as well as unfractionated heparin, factor Xinhibitors, combined thrombin/factor Xinhibitors, fibrinogen receptor antagonists (glycolprotein IIb/IIa antagonists) and Vitamin K antagonists, optionally together with one or more pharmaceutically acceptable excipients or carriers for the treatment of thrombosis.

New Indications For Direct Thrombin Inhibitors In The Cardiovascular Field
view source
US Patent:

20080039391, Feb 14, 2008
Filed:

Jul 17, 2007
Appl. No.:

11/779029
Inventors:

Andreas Clemens - Wiesbaden, DE
Paul Reilly - Ridgefield CT, US
Bernd Plohmann - Schemmerhofen, DE
Assignee:

Boehringer Ingelheim International GmbH - Ingelheim
International Classification:

A61K 31/4439
A61K 31/397
A61K 31/4709
A61K 38/17
A61P 9/00
US Classification:

514012000, 514210170, 514314000, 514338000
Abstract:

The invention relates to new indications for direct thrombin inhibitors such as dabigatran etexilate in the cardiovascular field.

Indications For Direct Thrombin Inhibitors
view source
US Patent:

20080200514, Aug 21, 2008
Filed:

Jul 17, 2007
Appl. No.:

11/778748
Inventors:

Andreas Clemens - Wiesbaden, DE
Paul A. Reilly - Ridgefield CT, US
Assignee:

Boehringer Ingelheim International GmbH - Ingelheim
International Classification:

A61K 31/4439
A61P 25/28
US Classification:

514338
Abstract:

The invention relates to new indications for direct thrombin inhibitors such as dabigatran etexilate in the CNS and other fields.

New Indications For Direct Thrombin Inhibitors
view source
US Patent:

20100173947, Jul 8, 2010
Filed:

Mar 22, 2010
Appl. No.:

12/728732
Inventors:

Andreas Clemens - Wiesbaden, DE
Paul A. Reilly - Ridgefield CT, US
Assignee:

Boehringer Ingelheim International GmbH - Ingelheim
International Classification:

A61K 31/4439
A61K 31/4709
A61K 38/17
A61K 31/397
A61K 31/4184
A61P 35/00
A61P 25/28
A61P 29/00
A61P 13/12
A61P 7/02
US Classification:

514338, 514314, 514 12, 51421017, 514394
Abstract:

The invention relates to new indications for direct thrombin inhibitors such as dabigatran etexilate in the CNS and other fields.

New Pharmaceutical Compositions For Treatment Of Thrombosis
view source
US Patent:

20100184729, Jul 22, 2010
Filed:

Mar 19, 2010
Appl. No.:

12/727933
Inventors:

Paul A. Reilly - Danbury CT, US
James C. Gilbert - Bethlehem CT, US
Thomas H. Mueller - Danbury CT, US
Assignee:

Boehringer Ingelheim International GmbH - Ingelheim
International Classification:

A61K 31/616
A61K 31/4365
A61P 7/02
A61P 9/10
US Classification:

514161, 514301
Abstract:

The present invention relates to novel pharmaceutical compositions comprising at least one direct thrombin inhibitor and at least one additional active compound selected from the groups consisting of platelet inhibitors, low molecular weight heparins (LMWH) and heparinoids as well as unfractionated heparin, factor Xinhibitors, combined thrombin/factor Xinhibitors, fibrinogen receptor antagonists (glycolprotein IIb/IIa antagonists) and Vitamin K antagonists, optionally together with one or more pharmaceutically acceptable excipients or carriers for the treatment of thrombosis.

Method For Treating Or Preventing Thrombosis Using Dabigatran Etexilate Or A Salt Thereof With Improved Safety Profile Over Conventional Warfarin Therapy
view source
US Patent:

20100322869, Dec 23, 2010
Filed:

Jun 17, 2010
Appl. No.:

12/817347
Inventors:

Paul Anthony REILLY - Danbury CT, US
Assignee:

BOEHRINGER INGELHEIM INTERNATIONAL GMBH - Ingelheim am Rhine
International Classification:

A61K 31/4439
A61K 49/00
A61P 7/02
A61P 9/00
US Classification:

424 103, 514338
Abstract:

A method for preventing stroke in a patient suffering from atrial fibrillation, wherein the patient has at least one risk factor for major bleeding events, the method comprising administering to the patient 110 mg b.i.d. of dabigatran etexilate, optionally in the form of a pharmaceutically acceptable salt thereof.

Method For Treating Or Preventing Thrombosis Using Dabigatran Etexilate Or A Salt Thereof With Improved Efficacy Over Conventional Warfarin Therapy
view source
US Patent:

20100322870, Dec 23, 2010
Filed:

Jun 17, 2010
Appl. No.:

12/817369
Inventors:

Paul Anthony REILLY - Danbury CT, US
Assignee:

BOEHRINGER INGELHEIM INTERNATIONAL GMBH - Ingelheim
International Classification:

A61K 31/4439
A61K 49/00
A61P 7/02
A61P 9/06
A61P 9/10
A61P 9/00
US Classification:

424 103, 514338
Abstract:

A method for preventing stroke in a patient suffering from atrial fibrillation, wherein the patient has no risk factors for major bleeding events, the method comprising administering to the patient 150 mg b.i.d. of dabigatran etexilate, optionally in the form of a pharmaceutically acceptable salt thereof.

Method For Treating Or Preventing Thrombosis Using Dabigatran Etexilate Or A Salt Thereof With Improved Efficacy Over Conventional Warfarin Therapy
view source
US Patent:

20110251160, Oct 13, 2011
Filed:

Nov 10, 2009
Appl. No.:

13/128463
Inventors:

Paul Anthony Reilly - Danbury CT, US
Assignee:

BOEHRINGER INGELHEIM INTERNATIONAL GMBH - Ingelheim
International Classification:

A61K 31/443
A61K 31/4709
C07D 401/12
A61K 31/616
A61P 9/10
A61P 7/02
US Classification:

514161, 514338, 5462734, 514305
Abstract:

A method for preventing stroke in a patient suffering from atrial fibrillation, wherein the patient has no risk factors for major bleeding events, the method comprising administering to the patient a dosage of >150 mg b.i.d. to 300 mg b.i.d. of dabigatran etexilate, optionally in the form of a pharmaceutically acceptable salt thereof.

License Records

Paul Reilly

License #:

0402010231

Category:

Professional Engineer License

Paul Anthony Reilly

License #:

MT009968T - Expired

Category:

Medicine

Type:

Graduate Medical Trainee

Wikipedia References

Paul Reilly

Work:

Position:

IBM employee • Computer scientist

Education:

Studied at:

University of Leeds

News

RI's Economy Ranks 41st in US in New Study

view source

You may not know the name, but you have probably tasted the food. Paul Reilly oversees maybe the largest and most diversified restaurant group in Rhode Island. In a state loaded with great restaurateurs, Reillys collection is impressive: Castle Hill Inn; TRIO and 22 Bowens Wine Bar & Grille; t
Date: Jun 06, 2016
Category: Business
Source: Google

Monitoring, Dose Adjustment for Pradaxa?

view source

While there's no extensive data published to prove it, variability in blood concentrations is likely for the other newer oral anticoagulants -- such as apixaban (Eliquis), rivaroxaban (Xarelto), and edoxaban (Savaysa) -- too, according to a letter from Boehringer employee Paul Reilly, PhD, and R
Date: Jul 23, 2014
Category: Health
Source: Google

UK AAA downgrade weighs on pound - live

view source

10.00 Paul Reilly of foreign exchange specialists Clear Currency has pointed out that a weaker currency is not an inevitable consequence of a downgrade. The US dollar has strengthened since it lost its AAA rating in August 2011.
Date: Feb 25, 2013
Category: Business
Source: Google

Industrial Production in U.S. Jumps on Rebound From Sandy

view source

I cant help but think that after, what I would calleight to 10 quarters of a weakening world economy, that sometimein 2013 we need to get to a point in time where there is a morerobust environment, Paul Reilly, chief financial officer ofArrow Electronics Inc. (ARW), said during a Dec. 11 conf
Date: Dec 14, 2012
Category: Business
Source: Google

Raymond James Snags Morgan Keegan For $930 Million

view source

Thats what Paul Reilly said he was looking for after the companys last earnings report in October. The Raymond James CEO took a pretty big bite Wednesday with the $930 million acquisition of brokerage firm Morgan Keegan.
Date: Jan 11, 2012
Category: Business
Source: Google

Arrow moves HQ off LI to Colorado

view source

Arrow CEO Michael J. Long has been based in Englewood, Colo., since taking the helm in 2009, succeeding Bill Mitchell, who had been based in Melville. Arrow CFO Paul Reilly will remain based on Long Island.
Date: Oct 11, 2011
Category: Business
Source: Google